在瘤微环境中克服T细胞耗尽,通过使用纳米输送系统进行免疫检查点调制,用于增强免疫疗法
1Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China.
Small methods
|December 1, 2023
概括
将免疫检查点阻塞 (ICB) 疗法与纳米输送系统相结合,可以克服瘤微环境 (TME) 中的T细胞耗尽. 这种方法提高了免疫治疗反应率,并减少了与高剂量抗体治疗相关的副作用.
科学领域:
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
- 纳米技术 纳米技术
背景情况:
- 免疫检查点阻塞 (ICB) 疗法在治疗瘤方面表现有前途,但也面临着挑战.
- 对ICB的低响应率通常是由于瘤微环境 (TME) 内的抑制性免疫细胞透.
- 目前的ICB疗法需要高剂量和长期使用,导致与免疫相关的不良影响.
研究的目的:
- 审查将ICB与纳米输送系统相结合的战略.
- 通过在TME中克服T细胞枯竭来增强免疫疗法.
- 为了减少副作用,提高抗体在癌症治疗中的有效性.
主要方法:
- 对ICB和纳米传递系统的现有文献的审查.
- 综合纳米输送系统与ICB集成的战略,以改善免疫治疗的总结.
- 探索表面表达,药物加载,基因编辑和使用纳米载体的直接调制等方法.
主要成果:
- 纳米输送系统提供了一种方法来克服T细胞在TME的耗尽.
- 将ICB与纳米输送系统相结合,可以提高免疫治疗的疗效.
- 降低抗体剂量和减少不良反应的可能性.
结论:
- 结合ICB和纳米输送系统,为克服T细胞枯竭提供了一个有希望的策略.
- 这种综合方法有可能显著改善癌症免疫治疗结果.
- 对这些组合方式的进一步研究有必要进行临床转化.
相关概念视频
Tumor Immunotherapy
529
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
529
The Tumor Microenvironment
6.6K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.6K
Cytotoxic T Cells-mediated Immune Response
923
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
923


